Julian K.-C. Ma

What is he best known for?

The fields of study he is best known for:

• Gene
• Antibody
• Enzyme

His main research concerns Antibody, Biotechnology, Plantibody, Monoclonal antibody and Streptococcus mutans. The various areas that he examines in his Antibody study include Virus, Ebola virus and Virology. He combines subjects such as Genetically modified crops and Marketing with his study of Biotechnology.

His Plantibody research is multidisciplinary, incorporating perspectives in Molecular biology and Recombinant DNA. The concepts of his Molecular biology study are interwoven with issues in Immunoglobulin light chain, Transgene and Immunoglobulin heavy chain. His Streptococcus mutans research includes elements of Immunology, Microbiology and Active immunization.

His most cited work include:

• The production of recombinant pharmaceutical proteins in plants. (792 citations)
• Generation and assembly of secretory antibodies in plants. (571 citations)
• Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. (443 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Antibody, Monoclonal antibody, Virology, Recombinant DNA and Molecular biology. The study incorporates disciplines such as Nicotiana benthamiana, Antigen and Microbiology in addition to Antibody. His research investigates the connection with Monoclonal antibody and areas like Biochemistry which intersect with concerns in Immunoglobulin G.

He works mostly in the field of Virology, limiting it down to concerns involving Adjuvant and, occasionally, Immunogenicity. His Recombinant DNA research includes themes of Transgene and Glycoprotein. His study in Molecular biology is interdisciplinary in nature, drawing from both Immunoglobulin light chain, Affinity chromatography and Plantibody.

He most often published in these fields:

• Antibody (44.88%)
• Monoclonal antibody (32.28%)
• Virology (24.41%)

What were the highlights of his more recent work (between 2016-2021)?

• Antibody (44.88%)
• Virology (24.41%)
• Rabies virus (7.09%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Antibody, Virology, Rabies virus, Antigen and Monoclonal antibody. His Antibody research incorporates themes from Microbiology, Recombinant DNA, Fusion protein and Cell biology. He interconnects Defensin and Ectodomain in the investigation of issues within Recombinant DNA.

His Virology research incorporates elements of Griffithsin, Nicotiana tabacum and Bacteria. His Rabies virus study combines topics in areas such as Molecular biology, Glycoprotein and Affinity chromatography. His Monoclonal antibody research is multidisciplinary, incorporating elements of Receptor, Glycosylation and N-linked glycosylation.

Between 2016 and 2021, his most popular works were:

• Potential Applications of Plant Biotechnology against SARS-CoV-2. (43 citations)
• Synthetic gene design-The rationale for codon optimization and implications for molecular pharming in plants. (30 citations)
• Recombinant biologic products versus nutraceuticals from plants - a regulatory choice? (18 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Antibody
• Enzyme

Julian K.-C. Ma spends much of his time researching Biotechnology, Antibody, Pharmaceutical manufacturing, Biologic Products and Nutraceutical. His Biotechnology research overlaps with other disciplines such as Sars virus, 2019-20 coronavirus outbreak, Research community, Pandemic and Severe acute respiratory syndrome coronavirus 2. His research integrates issues of Receptor and Biochemistry in his study of Antibody.

Julian K.-C. Ma connects Pharmaceutical manufacturing with Biochemical engineering in his research.